ATE513836T1 - Benzimidazoä1,2-cüä1,2,3üthiadiazol-7- sulfonsäureamide als carboanhydraseinhibitoren und zwischenprodukte zu deren herstellung - Google Patents

Benzimidazoä1,2-cüä1,2,3üthiadiazol-7- sulfonsäureamide als carboanhydraseinhibitoren und zwischenprodukte zu deren herstellung

Info

Publication number
ATE513836T1
ATE513836T1 AT07793796T AT07793796T ATE513836T1 AT E513836 T1 ATE513836 T1 AT E513836T1 AT 07793796 T AT07793796 T AT 07793796T AT 07793796 T AT07793796 T AT 07793796T AT E513836 T1 ATE513836 T1 AT E513836T1
Authority
AT
Austria
Prior art keywords
cüä1
production
sulfonic acid
acid amides
intermediate products
Prior art date
Application number
AT07793796T
Other languages
English (en)
Inventor
Daumantas Matulis
Virginija Dudutiene
Jurgita Matuliene
Lina Mistinaite
Original Assignee
Biotechnologijos Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnologijos Inst filed Critical Biotechnologijos Inst
Application granted granted Critical
Publication of ATE513836T1 publication Critical patent/ATE513836T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07793796T 2006-08-02 2007-08-01 Benzimidazoä1,2-cüä1,2,3üthiadiazol-7- sulfonsäureamide als carboanhydraseinhibitoren und zwischenprodukte zu deren herstellung ATE513836T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LT2006066A LT5504B (lt) 2006-08-02 2006-08-02 Benzimidazo[1,2-c][1,2,3]tiadiazolo sulfonamidai - karboanhidrazių slopikliai ir tarpiniai junginiai jiems gauti
PCT/LT2007/000005 WO2008016288A1 (en) 2006-08-02 2007-08-01 Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof

Publications (1)

Publication Number Publication Date
ATE513836T1 true ATE513836T1 (de) 2011-07-15

Family

ID=38616554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07793796T ATE513836T1 (de) 2006-08-02 2007-08-01 Benzimidazoä1,2-cüä1,2,3üthiadiazol-7- sulfonsäureamide als carboanhydraseinhibitoren und zwischenprodukte zu deren herstellung

Country Status (4)

Country Link
EP (1) EP2054420B1 (de)
AT (1) ATE513836T1 (de)
LT (1) LT5504B (de)
WO (1) WO2008016288A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201106548D0 (en) * 2011-04-18 2011-06-01 Evitraproteoma Ab A method for determining ligand binding to a target protein using a thermal shift assahy
CN105362890A (zh) * 2015-12-18 2016-03-02 杜小卫 一种治疗女性肾虚症的中药药酒

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975447A (en) 1983-02-04 1990-12-04 University Of Iowa Research Foundation 6-hydroxyethoxy-2-benzothiazolesulfonamide and topical treatment compositions and method for glaucoma
US4788192A (en) 1983-06-20 1988-11-29 Merck & Co., Inc. 2-Sulfamoylbenzo(b)thiophene derivatives pharmaceutical compositions and use
US4668697A (en) 1983-10-31 1987-05-26 Merck & Co., Inc. Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor
US4929637A (en) 1985-12-24 1990-05-29 Merck & Co., Inc. Substituted thiophene-2-sulfonamide antiglaucoma agents
US4731368A (en) 1986-12-08 1988-03-15 Merck & Co., Inc. Thienopyridine sulfonamides and their ophthalmological formulation
US4847289A (en) 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
US4894390A (en) 1987-08-03 1990-01-16 Merck & Co., Inc. Substituted thieno[2,3-b]thiophene-2-sulfonamides as antiglaucoma agents
US4751231A (en) 1987-09-16 1988-06-14 Merck & Co., Inc. Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
US4798831A (en) 1987-09-16 1989-01-17 Merck & Co., Inc. Substituted thieno[2,3-B]furan-2-sulfonamides as antiglaucoma agents
US4929549A (en) 1989-02-08 1990-05-29 Merck & Co., Inc. 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors
US5120757A (en) 1989-07-31 1992-06-09 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents
US5059613A (en) 1990-03-19 1991-10-22 Research Corporation Technologies, Inc. Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
US5378703A (en) 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
US5153192A (en) 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
US5157129A (en) 1990-04-18 1992-10-20 Merck & Co., Inc. Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide
US5091409A (en) 1990-05-17 1992-02-25 Merck & Co., Inc. 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides
US5093332A (en) 1990-10-01 1992-03-03 Merck & Co., Inc. Substituted thieno(2,3-b)(1,4)thiazine-6-sulfonamides as antiglaucoma agents
SG84487A1 (en) 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
US5235059A (en) * 1991-10-15 1993-08-10 Merck & Co., Inc. Tricyclic thienothiopyran carbonic anhydrase inhibitors
US5344929A (en) 1993-02-18 1994-09-06 Alcon Laboratories, Inc. Preparation of carbonic anhydrase inhibitors
US5538966A (en) 1994-01-21 1996-07-23 Alcon Laboratories, Inc. Carbonic anhydrase inhibitors
US5519040A (en) 1994-04-29 1996-05-21 Allergan Substituted thiazole sulfonamides as antiglaucoma agents
US5646142A (en) 1994-07-08 1997-07-08 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
US6316443B1 (en) 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
US5510347A (en) 1994-09-09 1996-04-23 Alcon Laboratories, Inc. Thienothiadiazine sulfonamides useful as carbonic anhydrase inhibitors
US5464831A (en) 1994-09-09 1995-11-07 Alcon Laboratories, Inc. Thienothiadiazine sulfonamides useful as carbonic anhydrase inhibitors
US5681834A (en) * 1995-12-04 1997-10-28 Alcon Laboratories, Inc. Heterocyclic sulfonamides
ES2177415B1 (es) 2000-09-04 2004-10-16 Ragactives, S.L. Procedimiento para la obtencion de 4-alquilamino-5, 6-dihidro-4h-tieno-(2,3b)-tiopiran-2-sulfonamida-7-dioxidos, e intermedios.
WO2003013655A2 (en) * 2001-08-10 2003-02-20 Pharmacia Corporation Carbonic anhydrase inhibitors
DK2594265T3 (en) 2002-11-26 2015-12-21 Inst Virology CA IX-specific inhibitors
WO2005107470A2 (en) 2004-04-29 2005-11-17 University Of Florida Research Foundation, Inc. Use of carbonic anhydrase inhibitors for insect control and malaria treatment

Also Published As

Publication number Publication date
LT2006066A (en) 2008-02-25
EP2054420B1 (de) 2011-06-22
LT5504B (lt) 2008-06-25
EP2054420A1 (de) 2009-05-06
WO2008016288A1 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
NO20091560L (no) Biaryleterureaforbindelser
MY169962A (en) 2-amino-5,5-difluoro-5,6-dihydro-oxazines as bace 1 and/or bace 2 inhibitors
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
PL1776349T3 (pl) Pochodne 2-amino-chinazoliny użyteczne jako inhibitory beta-sekretazy (BACE)
SI1789398T1 (sl) 2-amino-kinazolinski derivati, uporabni kot inhibitorji b-sekretaze (bace)
EP1817312A4 (de) Makrozyklische aminiopyridyl-beta-sekretase-hemmer zur behandlung von morbus alzheimer
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
NO20052520L (no) Nye sulfamider
MX2013008478A (es) 1, 4 riazepinas/sulfonas como inhibidores de beta secretasa 1 (base1) y/o beta secretasa 2 (bace2).
MEP60508A (en) Acylated arylcycloalkylamines and their use as pharmaceuticals
ECSP045378A (es) Derivados novedosos de diazabiciclononeno
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
MA30296B1 (fr) Nouvelles amines
ZA200701798B (en) Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors
MA30292B1 (fr) Amines primaires comme inhibiteurs de la renine
ATE538796T1 (de) Piperidin- und pyrrolidin-beta-secretase-hemmer zur behandlung von alzheimer-krankheit
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
ATE513836T1 (de) Benzimidazoä1,2-cüä1,2,3üthiadiazol-7- sulfonsäureamide als carboanhydraseinhibitoren und zwischenprodukte zu deren herstellung
NO330964B1 (no) Kolkisosidanaloger
NO20090067L (no) Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer
EP2073635A4 (de) Makrozyklische spiropiperidin-beta-sekretase-hemmer zur behandlung von morbus alzheimer
TW200621774A (en) Bicyclononene derivatives
EP1912963A4 (de) Cyclische ketale als beta-sekretase-inhibitoren zur behandlung von alzheimer-krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties